161 related articles for article (PubMed ID: 15881330)
1. [Mechanisms of action of transportation of liposomes and chitosan-coated liposomes containing leuprolide across intestine and Caco-2 cell].
Guo JX; Ping QN; Dong J; Li ZR; Li CJ
Yao Xue Xue Bao; 2005 Jan; 40(1):65-70. PubMed ID: 15881330
[TBL] [Abstract][Full Text] [Related]
2. Transport of leuprolide across rat intestine, rabbit intestine and Caco-2 cell monolayer.
Guo J; Ping Q; Jiang G; Dong J; Qi S; Feng L; Li Z; Li C
Int J Pharm; 2004 Jul; 278(2):415-22. PubMed ID: 15196645
[TBL] [Abstract][Full Text] [Related]
3. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE
Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606
[TBL] [Abstract][Full Text] [Related]
4. [Effects of the liposomes coated by chitosan and its derivatives on the gastrointestinal transit of insulin].
Wu ZH; Ping QN; Lei XM; Li JY; Cai P
Yao Xue Xue Bao; 2005 Jul; 40(7):618-22. PubMed ID: 16196267
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs.
Takeuchi H; Matsui Y; Sugihara H; Yamamoto H; Kawashima Y
Int J Pharm; 2005 Oct; 303(1-2):160-70. PubMed ID: 16125348
[TBL] [Abstract][Full Text] [Related]
6. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization.
Shahnaz G; Vetter A; Barthelmes J; Rahmat D; Laffleur F; Iqbal J; Perera G; Schlocker W; Dünnhaput S; Augustijns P; Bernkop-Schnürch A
Int J Pharm; 2012 May; 428(1-2):164-70. PubMed ID: 22421322
[TBL] [Abstract][Full Text] [Related]
7. Thiolated chitosan: development and in vivo evaluation of an oral delivery system for leuprolide.
Iqbal J; Shahnaz G; Perera G; Hintzen F; Sarti F; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2012 Jan; 80(1):95-102. PubMed ID: 21964316
[TBL] [Abstract][Full Text] [Related]
8. Transmucosal macromolecular drug delivery.
Prego C; García M; Torres D; Alonso MJ
J Control Release; 2005 Jan; 101(1-3):151-62. PubMed ID: 15588901
[TBL] [Abstract][Full Text] [Related]
9. Hypoglycemic efficacy of chitosan-coated insulin liposomes after oral administration in mice.
Wu ZH; Ping QN; Wei Y; Lai JM
Acta Pharmacol Sin; 2004 Jul; 25(7):966-72. PubMed ID: 15210073
[TBL] [Abstract][Full Text] [Related]
10. Thiolated chitosans: development and in vitro evaluation of an oral tobramycin sulphate delivery system.
Hombach J; Hoyer H; Bernkop-Schnürch A
Eur J Pharm Sci; 2008 Jan; 33(1):1-8. PubMed ID: 17980561
[TBL] [Abstract][Full Text] [Related]
11. Methylated N-(4-N,N-dimethylaminobenzyl) chitosan coated liposomes for oral protein drug delivery.
Kowapradit J; Apirakaramwong A; Ngawhirunpat T; Rojanarata T; Sajomsang W; Opanasopit P
Eur J Pharm Sci; 2012 Sep; 47(2):359-66. PubMed ID: 22771544
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
Rekha MR; Sharma CP
J Control Release; 2009 Apr; 135(2):144-51. PubMed ID: 19331862
[TBL] [Abstract][Full Text] [Related]
13. Effect of chitosan glutamate, carbomer 974P, and EDTA on the in vitro Caco-2 permeability and oral pharmacokinetic profile of acyclovir in rats.
Merzlikine A; Rotter C; Rago B; Poe J; Christoffersen C; Thomas VH; Troutman M; El-Kattan A
Drug Dev Ind Pharm; 2009 Sep; 35(9):1082-91. PubMed ID: 19294548
[TBL] [Abstract][Full Text] [Related]
14. Transport characteristics of 9-nitrocamptothecin in the human intestinal cell line Caco-2 and everted gut sacs.
Sha X; Fang X
Int J Pharm; 2004 Mar; 272(1-2):161-71. PubMed ID: 15019079
[TBL] [Abstract][Full Text] [Related]
15. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.
Yin L; Ding J; He C; Cui L; Tang C; Yin C
Biomaterials; 2009 Oct; 30(29):5691-700. PubMed ID: 19615735
[TBL] [Abstract][Full Text] [Related]
16. Novel O-palmitoylscleroglucan-coated liposomes as drug carriers: development, characterization and interaction with leuprolide.
Carafa M; Marianecci C; Annibaldi V; Di Stefano A; Sozio P; Santucci E
Int J Pharm; 2006 Nov; 325(1-2):155-62. PubMed ID: 16884870
[TBL] [Abstract][Full Text] [Related]
17. Liposomes coated with N-trimethyl chitosan to improve the absorption of harmine in vivo and in vitro.
Chen WL; Yuan ZQ; Liu Y; Yang SD; Zhang CG; Li JZ; Zhu WJ; Li F; Zhou XF; Lin YM; Zhang XN
Int J Nanomedicine; 2016; 11():325-36. PubMed ID: 26855571
[TBL] [Abstract][Full Text] [Related]
18. Improved delivery of cromolyn from oral proliposomal beads.
Deshmukh DD; Ravis WR; Betageri GV
Int J Pharm; 2008 Jun; 358(1-2):128-36. PubMed ID: 18400424
[TBL] [Abstract][Full Text] [Related]
19. [Preparation and characterization of chitosan coated puerarin liposomes].
Wang HG; Zhai GX; Lü QZ; Ling PX
Zhong Yao Cai; 2007 Jan; 30(1):89-92. PubMed ID: 17539312
[TBL] [Abstract][Full Text] [Related]
20. [Studies on the insulin-liposomes double-coated by chitosan and chitosan-EDTA conjugates].
Wu ZH; Ping QN; Song YM; Lei XM; Li JY; Cai P
Yao Xue Xue Bao; 2004 Nov; 39(11):933-8. PubMed ID: 15696937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
